Form D Explorer

Form D — Dewpoint Therapeutics, Inc.

0001828893-25-000002 · filed 2025-09-23

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $59,124,298
Total sold: $59,124,298
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Dewpoint Therapeutics, Inc.
CIK: 1828893
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 451 D Street, Suite 104
Boston, MA 02210
Phone: 617-914-8448

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Ameet Nathwani, M.D. · Executive Officer

Boston, MA Find on LinkedIn ↗
Srinivas Akkaraju, M.D., Ph.D. · Director

Boston, MA Find on LinkedIn ↗
Regina Barzilay, Ph.D. · Director

Boston, MA Find on LinkedIn ↗
Olivier Brandicourt, M.D. · Director

Boston, MA Find on LinkedIn ↗
Guiseppe A. Ciaramella, Ph,D. · Director

Boston, MA Find on LinkedIn ↗
Anthony A. Hyman, Ph.D. · Director

Boston, MA Find on LinkedIn ↗
Mark Murcko, Ph.D. · Director

Boston, MA Find on LinkedIn ↗
Amir H. Nashat, Ph.D. · Director

Boston, MA Find on LinkedIn ↗
Fabio Pucci, Ph.D. · Director

Boston, MA Find on LinkedIn ↗
Richard A. Young, Ph.D. · Director

Boston, MA Find on LinkedIn ↗
Isaac A. Klein, M.D., Ph.D. · Executive Officer

Boston, MA Find on LinkedIn ↗
Lori Escobedo · Executive Officer

Boston, MA Find on LinkedIn ↗
Elisabeth Leiderman · Executive Officer

Boston, MA Find on LinkedIn ↗

View original on SEC EDGAR.